Prostate Cancer Screening Guidelines for Black Men: Spotlight on an Empty Stage
Menée à partir des données 2004-2017 des registres américains des cancers et à partir des données 2012-2018 du "Behavioral Risk Factor Surveillance System", cette étude analyse, en fonction de l'appartenance ethnique et de l'âge, l'évolution du taux de patients ayant bénéficié d'un dépistage du cancer de la prostate par dosage du PSA après les recommandations en 2012 de l'"United States Preventive Services Task Force"
A two-fold or more increase drisk of prostate cancer death among Black men in the US has been on record since the National Cancer Institute began its Surveillance, Epidemiology and End Result (SEER) program.In 2008-2012, just before the US Preventive Services Task Force (USPSTF) recommended against routine prostate specific antigen (PSA) screening for prostate cancer, the age-adjusted mortality among Black men was 2.4-times that among White men, exceeding Black men’s 1. 7-fold increased incidence. It is now well understood that societal factors and lack of access to quality care explain a large portion of the excess mortality among Black men, and that translational health services solutions are needed to narrow the gap and improve prostate cancer outcomes in this high-risk population.
Journal of the National Cancer Institute , éditorial en libre accès, 2019